Literature DB >> 28835502

CD8+ T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection.

Huarong Huang1,2, Shihua Li1, Yongli Zhang3, Xiaojuan Han1,2, Baoqian Jia1, Hongtao Liu1,2, Dandan Liu1,2, Shuguang Tan1, Qihui Wang1, Yuhai Bi1, William J Liu3, Baidong Hou4, George Fu Gao5,6,3,7, Fuping Zhang5,6.   

Abstract

Zika virus (ZIKV) infection causees neurologic complications, including Guillain-Barré syndrome in adults and central nervous system (CNS) abnormalities in fetuses. We investigated the immune response, especially the CD8+ T cell response in C57BL/6 (B6) wild-type (WT) mice, during ZIKV infection. We found that a robust CD8+ T cell response was elicited, major histocompatibility complex class I-restricted CD8+ T cell epitopes were identified, a tetramer that recognizes ZIKV-specific CD8+ T cells was developed, and virus-specific memory CD8+ T cells were generated in these mice. The CD8+ T cells from these infected mice were functional, as evidenced by the fact that the adoptive transfer of ZIKV-specific CD8+ T cells could prevent ZIKV infection in the CNS and was cross protective against dengue virus infection. Our findings provide comprehensive insight into immune responses against ZIKV and further demonstrate that WT mice could be a natural and easy-access model for evaluating immune responses to ZIKV infection.IMPORTANCE ZIKV infection has severe clinical consequences, including Guillain-Barré syndrome in adults, microcephaly, and congenital malformations in fetuses and newborn infants. Therefore, study of the immune response, especially the adaptive immune response to ZIKV infection, is important for understanding diseases caused by ZIKV infection. Here, we characterized the CD8+ T cell immune response to ZIKV in a comprehensive manner and identified ZIKV epitopes. Using the identified immunodominant epitopes, we developed a tetramer that recognizes ZIKV-specific CD8+ T cells in vivo, which simplified the detection and evaluation of ZIKV-specific immune responses. In addition, the finding that tetramer-positive memory CD8+ T cell responses were generated and that CD8+ T cells can traffic to a ZIKV-infected brain greatly enhances our understanding of ZIKV infection and provides important insights for ZIKV vaccine design.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CD8+ T cell; ZIKV; central nervous system; cross protection; immunocompetent mouse model

Mesh:

Substances:

Year:  2017        PMID: 28835502      PMCID: PMC5660488          DOI: 10.1128/JVI.00900-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Evasion of innate and adaptive immunity by flaviviruses.

Authors:  Michael S Diamond
Journal:  Immunol Cell Biol       Date:  2003-06       Impact factor: 5.126

2.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

3.  Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.

Authors:  Jun Liu; Bin Wu; Shihong Zhang; Shuguang Tan; Yeping Sun; Zhujun Chen; Yuanfang Qin; Mingwei Sun; Guoli Shi; Ying Wu; Meiyi Sun; Na Liu; Kaida Ning; Ying Ma; Bin Gao; Jinghua Yan; Fengcai Zhu; Hua Wang; George F Gao
Journal:  Eur J Immunol       Date:  2013-06-14       Impact factor: 5.532

4.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Authors:  Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

5.  CNS infections: Zika virus infection could trigger Guillain-Barré syndrome.

Authors:  Hemi Malkki
Journal:  Nat Rev Neurol       Date:  2016-03-18       Impact factor: 42.937

6.  Immunogenic cross-talk between dengue and Zika viruses.

Authors:  Stephen C Harrison
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

7.  Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells.

Authors:  James R Bowen; Kendra M Quicke; Mohan S Maddur; Justin T O'Neal; Circe E McDonald; Nadia B Fedorova; Vinita Puri; Reed S Shabman; Bali Pulendran; Mehul S Suthar
Journal:  PLoS Pathog       Date:  2017-02-02       Impact factor: 6.823

8.  Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation.

Authors:  Jovana Cupovic; Lucas Onder; Cristina Gil-Cruz; Elke Weiler; Sonja Caviezel-Firner; Christian Perez-Shibayama; Thomas Rülicke; Ingo Bechmann; Burkhard Ludewig
Journal:  Immunity       Date:  2016-02-23       Impact factor: 31.745

Review 9.  The great balancing act: regulation and fate of antiviral T-cell interactions.

Authors:  E Ashley Moseman; Dorian B McGavern
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

10.  Characterization of a Novel Murine Model to Study Zika Virus.

Authors:  Shannan L Rossi; Robert B Tesh; Sasha R Azar; Antonio E Muruato; Kathryn A Hanley; Albert J Auguste; Rose M Langsjoen; Slobodan Paessler; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

View more
  62 in total

1.  Persistent Zika Virus Clinical Susceptibility despite Reduced Viral Burden in Mice with Expanded Virus-Specific CD8+ T Cells Primed by Recombinant Listeria monocytogenes.

Authors:  Ashley R Burg; John J Erickson; Lucien H Turner; Giang Pham; Jeremy M Kinder; Sing Sing Way
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 2.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

Review 3.  Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  Curr Opin Immunol       Date:  2019-03-15       Impact factor: 7.486

Review 4.  T Cell Immunity to Zika and Dengue Viral Infections.

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  J Interferon Cytokine Res       Date:  2017-11       Impact factor: 2.607

5.  Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.

Authors:  Kun Xu; Yufeng Song; Lianpan Dai; Yongli Zhang; Xuancheng Lu; Yijia Xie; Hangjie Zhang; Tao Cheng; Qihui Wang; Qingrui Huang; Yuhai Bi; William J Liu; Wenjun Liu; Xiangdong Li; Chuan Qin; Yi Shi; Jinghua Yan; Dongming Zhou; George F Gao
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection.

Authors:  Gage K Moreno; Christina M Newman; Michelle R Koenig; Mariel S Mohns; Andrea M Weiler; Sierra Rybarczyk; Kim L Weisgrau; Logan J Vosler; Nicholas Pomplun; Nancy Schultz-Darken; Eva Rakasz; Dawn M Dudley; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

Review 7.  Mathematical modeling of within-host Zika virus dynamics.

Authors:  Katharine Best; Alan S Perelson
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

Review 8.  Using immunocompromised mice to identify mechanisms of Zika virus transmission and pathogenesis.

Authors:  Clayton W Winkler; Karin E Peterson
Journal:  Immunology       Date:  2018-01-19       Impact factor: 7.397

9.  Generation of Zika virus-specific T cells from seropositive and virus-naïve donors for potential use as an autologous or "off-the-shelf" immunotherapeutic.

Authors:  Ryo Hanajiri; Gelina M Sani; Patrick J Hanley; Cassia G Silveira; Esper G Kallas; Michael D Keller; Catherine M Bollard
Journal:  Cytotherapy       Date:  2019-07-04       Impact factor: 5.414

Review 10.  Zika virus vaccines: immune response, current status, and future challenges.

Authors:  Justin M Richner; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.